| Literature DB >> 30141311 |
Jorma Sormunen1,2, Madar Talibov, Pär Sparén, Jan Ivar Martinsen, Elisabete Weiderpass, Eero Pukkala.
Abstract
The evidence that prostate cancer is associated to physical inactivity is inconsistent. We studied the association of perceived physical workload (PPWL) at work and incidence of prostate cancer in a case-control setting. We used data from the Nordic Occupational Cancer study from Finland and Sweden. Five population controls were selected for each prostate cancer patient, matched on age and country. We had 239,835 cases and 1,199,175 controls in our study. For each case and control we estimated cumulative PPWL based on probability, level and duration of PPWL using the NOCCA Job Exposure Matrix. We then stratified individuals as having no exposure (reference category), low physical activity (below 50th percentile of the exposed), moderate exposure (50th-90th percentile) and high exposure (90th percentile and higher). The hazard ratios for prostate cancer from the lowest to highest cumulative PPWL levels were 0.90 (95% confidence interval 0.89-0.91), 0.88 (0.87-0.89) and 0.93 (0.92-0.95). There was no statistically significant dose response effect of PPWL on prostate cancer incidence. Inclusion of socioeconomic status in the model did not substantially change the result. The results were similar before Prostate Specific Antigen (PSA) testing and during the years of PSA testing in these countries. In summary, individuals with physical strain at work had a lower risk of invasive prostate cancer as compared to individuals without physical strain at work. Creative Commons Attribution LicenseEntities:
Keywords: Epidemiology; invasive prostate cancer; physical workload
Mesh:
Year: 2018 PMID: 30141311 PMCID: PMC6171402 DOI: 10.22034/APJCP.2018.19.8.2331
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Characteristics of Study Population for Prostate Cancer Data in Finland and Sweden
| Characteristics | Case | Control | ||
|---|---|---|---|---|
| n | % | N | % | |
| Total | 239,835 | 100 | 1,199,175 | 100 |
| Age at index date | ||||
| <40 | 22 | 0.0 | 105 | 0.0 |
| 40-60 | 20,198 | 8.4 | 101,515 | 8.5 |
| 60-80 | 175,645 | 73.2 | 877,070 | 73.1 |
| >80 | 43,970 | 18.3 | 220,485 | 18.4 |
| Country | ||||
| Finland | 58,921 | 24.6 | 294,605 | 24.6 |
| Sweden | 180,914 | 75.4 | 904,570 | 75.4 |
| Period | ||||
| Before 1990 (pre-PSA) | 83,772 | 34.9 | 418,860 | 34.9 |
| 1990-2005 (PSA) | 156,063 | 65.1 | 780,315 | 65.1 |
| Socio-economic status | ||||
| Upper white-collar | 59,318 | 24.7 | 257,201 | 21.5 |
| Lower white-collar | 83,527 | 34.8 | 424,643 | 35.4 |
| Upper blue-collar | 68,317 | 28.5 | 358,869 | 29.9 |
| Lower blue-collar | 14,102 | 5.9 | 78,631 | 6.6 |
| Farmer | 11,066 | 4.6 | 53,500 | 4.5 |
| Economically inactive | 3,503 | 1.5 | 26,331 | 2.2 |
Hazard Ratio (HR) and 95% Confidence Interval (95% CI) for Prostate Cancer, by Cumulative PPWL Exposure in Finland and Sweden, with an without Unadjustment for Socioeconomic Status (SES)
| Unadjusted | Adjusted for SES | |||||
|---|---|---|---|---|---|---|
| Exposure | HR | 95% CI | p-trend | HR | 95% CI | p-trend |
| Cumulative PPWL[ | ||||||
| Reference | 1.00 | Ref. | 1.00 | Ref. | ||
| Low | 0.90 | 0.89-0.91 | 0.94 | 0.93-0.95 | ||
| Moderate | 0.88 | 0.87-0.89 | 0.94 | 0.92-0.95 | ||
| High | 0.93 | 0.92-0.95 | <0.01 | 0.97 | 0.95-0.99 | <0.01 |
Cut-points are based on 50th and 90th percentile of exposure distribution among exposed subjects.
Hazard Ratio (HR) and 95% Confidence Interval (95% CI) for PPWL Exposure and Prostate Cancer in Finland and Sweden Stratified by PSA-period, with and without Adjustment for Socioeconomic Status (SES)
| Cumulative PPWL[ | Case | Control | Unadjusted | Adjusted for SES | ||||
|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | p-trend | HR | 95% CI | p-trend | |||
| Before 1990 (pre-PSA period) | ||||||||
| Reference | 30,205 | 144,069 | 1.00 | Ref. | 1.00 | Ref. | ||
| Low | 22,290 | 114,081 | 0.90 | 0.89-0.91 | 0.94 | 0.92-0.96 | ||
| Moderate | 21,980 | 114,294 | 0.88 | 0.87-0.89 | 0.94 | 0.92-0.96 | ||
| High | 9,297 | 46,416 | 0.93 | 0.92-0.95 | <0.01 | 0.99 | 0.95-1.02 | 0.01 |
| 1990 and later (PSA period) | ||||||||
| Reference | 56,720 | 261,649 | 1.00 | Ref. | 1.00 | Ref. | ||
| Low | 54,533 | 282,317 | 0.89 | 0.88-0.90 | 0.94 | 0.92-0.95 | ||
| Moderate | 38,548 | 204,829 | 0.87 | 0.86-0.88 | 0.93 | 0.92-0.95 | ||
| High | 6,262 | 31,520 | 0.92 | 0.89-0.95 | <0.01 | 0.96 | 0.93-1.00 | <0.01 |
Cut-points are based on 50th and 90th percentile of exposure distribution among exposed subjects.